New Guidance Outlining Total Artificial Disc Trial Design Issued

Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance

More from Archive

More from Medtech Insight